Trials / Terminated
TerminatedNCT00566462
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
This is a two-arm, double-blind, placebo-controlled study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | perampanel | 2 mg/d for 14 days followed by 4 mg/d for 14 days |
| DRUG | placebo | Matching placebo for for 14 days followed by 4 mg/d for 14 days |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2007-12-03
- Last updated
- 2018-09-06
- Results posted
- 2012-12-24
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00566462. Inclusion in this directory is not an endorsement.